WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 522499
CAS#: 1159500-34-1
Description: Selatogrel, also known as ACT-246475, is a reversible, selective, and potent antagonist of the platelet P2Y12 receptor. It therefore acts as a platelet aggregation inhibitor. Selatogrel dose-dependently blocks thrombus formation and displays a wide therapeutic window.
MedKoo Cat#: 522499
Name: Selatogrel
CAS#: 1159500-34-1
Chemical Formula: C28H39N6O8P
Exact Mass: 618.2567
Molecular Weight: 618.63
Elemental Analysis: C, 54.36; H, 6.35; N, 13.59; O, 20.69; P, 5.01
Selatogrel is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.
Synonym: ACT-246475; ACT 246475; ACT246475; Selatogrel.
IUPAC/Chemical Name: ((R)-3-(4-(butoxycarbonyl)piperazin-1-yl)-2-(6-((S)-3-methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carboxamido)-3-oxopropyl)phosphonic acid
InChi Key: FYXHWMQPCJOJCH-GMAHTHKFSA-N
InChi Code: InChI=1S/C28H39N6O8P/c1-3-4-16-42-28(37)33-14-12-32(13-15-33)27(36)23(19-43(38,39)40)30-26(35)22-17-24(34-11-10-21(18-34)41-2)31-25(29-22)20-8-6-5-7-9-20/h5-9,17,21,23H,3-4,10-16,18-19H2,1-2H3,(H,30,35)(H2,38,39,40)/t21-,23-/m0/s1
SMILES Code: O=C(N1CCN(C([C@@H](NC(C2=NC(C3=CC=CC=C3)=NC(N4CC[C@@H](C4)OC)=C2)=O)CP(O)(O)=O)=O)CC1)OCCCC
The following data is based on the product molecular weight 618.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
1: Caroff E, Hubler F, Meyer E, Renneberg D, Gnerre C, Treiber A, Rey M, Hess P,
Steiner B, Hilpert K, Riederer MA.
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-
3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and
Its Prodrug (ACT-281959), a Novel P2Y(12) Receptor Antagonist with a Wider
Therapeutic Window in the Rat Than Clopidogrel. J Med Chem. 2015 Nov 18. [Epub
ahead of print] PubMed PMID: 26550844.
2: Baldoni D, Bruderer S, Krause A, Gutierrez M, Gueret P, Astruc B, Dingemanse
J. A new reversible and potent P2Y12 receptor antagonist (ACT-246475):
tolerability, pharmacokinetics, and pharmacodynamics in a first-in-man trial.
Clin Drug Investig. 2014 Nov;34(11):807-18. doi: 10.1007/s40261-014-0236-8.
PubMed PMID: 25331625.